@windhamvp

WellDoc® Improves Hypoglycemia Prediction Model for Patients with Type 2 Diabetes

Type 2 Diabetes Hypoglycemia Prediction Technology Highlighted at The American Diabetes Association Annual Meeting. San Francisco, CA – June 16, 2014 – Researchers at WellDoc® today presented updated results of its … Continued

Novocure Announces the Presentation of Subgroup Survival Data for Recurrent Glioblastoma Patients Treated with NovoTTF™ Therapy

Analysis of PRiDe, a U.S. commercial registry of 457 recurrent glioblastoma patients, demonstrates that patients treated with NovoTTF Therapy at their first recurrence achieved a median overall survival of 20 … Continued